## Gene Summary
PTH1R, which stands for Parathyroid Hormone 1 Receptor, is a critical protein encoded in humans by the PTH1R gene. It is primarily a member of the G protein-coupled receptor family and plays essential roles in bone and mineral metabolism. PTH1R specifically binds to parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP), mediating their effects primarily in bone and kidney tissues. This receptor is involved in regulating calcium levels in the blood, promoting both bone formation and resorption depending on the physiological conditions.

## Gene Drugs, Diseases, Phenotypes, and Pathways
PTH1R is closely associated with several bone-related disorders. Mutations in this gene have been linked to diseases such as Jansen's metaphyseal chondrodysplasia and Blomstrand chondrodysplasia, both of which affect bone development and growth. The gene plays a seminal role in the PTH/PTHrP signaling pathway which is pivotal in skeletal development. The receptor's involvement in calcium and phosphate homeostasis locates it at the center of critical metabolic pathways affecting bone density and strength. Due to its central role in bone metabolism, PTH1R is also pertinent to studies and treatments related to osteoporosis and related phenotypes.

## Pharmacogenetics
From a pharmacogenetics perspective, PTH1R is relevant to treatments involving drugs that mimic or antagonize the action of PTH, particularly in conditions like osteoporosis. For example, Teriparatide, an analog of parathyroid hormone, targets PTH1R to stimulate bone formation and is used primarily in the treatment of severe osteoporosis. This interaction highlights the importance of understanding individual genetic variations in the PTH1R gene, which could influence the therapeutic outcomes of treatments with such drugs. Additionally, pharmacogenetic insights into PTH1R might help personalize treatment plans for bone diseases, improving efficacy and reducing adverse effects by tailoring therapies based on PTH1R genetic profiles.